Marie Wikström Lindholm
Direttore Tecnico/Scientifico/R&S presso SILENCE THERAPEUTICS PLC
Posizioni attive di Marie Wikström Lindholm
Società | Posizione | Inizio | Fine |
---|---|---|---|
SILENCE THERAPEUTICS PLC | Direttore Tecnico/Scientifico/R&S | 01/12/2023 | - |
Corporate Officer/Principal | 02/11/2020 | 01/12/2023 | |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Direttore/Membro del Consiglio | 18/01/2022 | - |
Storia della carriera di Marie Wikström Lindholm
Precedenti posizioni note di Marie Wikström Lindholm
Società | Posizione | Inizio | Fine |
---|---|---|---|
University of Lund | Corporate Officer/Principal | 01/01/1999 | 01/01/2000 |
Formazione di Marie Wikström Lindholm
University of Uppsala | Doctorate Degree |
Statistiche
Distribuzione geografica
Svezia | 3 |
Regno Unito | 2 |
Stati Uniti | 2 |
Posizioni
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Settori
Commercial Services | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
SILENCE THERAPEUTICS PLC | Commercial Services |
Aziende private | 1 |
---|---|
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Commercial Services |